Chemotherapy (preferably with a single chemotherapeutic agent) combined with capecitabine (including capecitabine monotherapy: when the preferred drug identified is capecitabine alone). for cholangiocarcinoma
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
22 Dec 2025: Trial registered, NCT07296666
The trials
NCT07296666: Adjuvant Chemotherapy for BTC Based on 3D-PTA